Your Notifications
All done, no notifications

Transarterial Radioembolization- TARE Cost in Malaysia

USD 8000 - USD 60000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

1
Days in Hospital
60-120 min
Procedure Time
70 - 90%
Success Rate
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 8000 - USD 60000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator

International Quality. Affordable Care.

How Much Does Transarterial Radioembolization Cost in Malaysia?

The cost of TARE in Malaysia generally varies between USD 15000 - USD 25000

The total cost varies depending on the type of liver cancer or liver metastases being treated, the complexity of the procedure, the number of treatment sessions required, the hospital's infrastructure, the expertise of the interventional radiology team, and the patient's overall health condition.

Factors Influencing the Cost of Transarterial Radioembolization

  • Hospital and location: Hospitals specialising in multiple areas, such as multi-speciality hospitals, or distinctive centres for liver cancer that already possess sophisticated infrastructure, are expected to impose higher rates due to their top-notch facilities and exclusive services.
  • Type and Extent of Cancer: The cost depends on whether TARE is performed for primary liver cancer (hepatocellular carcinoma) or liver metastases, as well as the size, number, and location of the tumours.
  • Technology and equipment: The adoption of advanced diagnostic technology and angiography equipment, and the prescription of Yttrium-90 microspheres, considerably influences the total amount spent on the treatment.
  • Expertise of interventional radiologist: When the treatment is conducted by a qualified interventional radiologist and qualified multidisciplinary liver cancer medical personnel, the professional fee shall be higher.
  • Pre-procedure evaluation: Expenses include preliminary evaluation, blood testing, CT scan, MRI and hepatic angiography, PET-CT, and mapping.
  • Patient's Overall Health: Patients with underlying liver disease, cirrhosis, or other medical conditions may require additional evaluation, supportive care, or longer hospital stays, increasing the total cost.
  • Post-Procedure Care: Follow-up consultations, imaging studies, medications, laboratory monitoring, and supportive care are additional expenses that should be considered.

What's included in your Transarterial Radioembolization- TARE quote?

Transarterial Radioembolization (TARE)
fee, Yttrium-90 (Y-90)
Oncology team consults
Pre-evaluation, treatment planning, follow-ups
1–2-day hospital stay
management
5–7-day in-country follow-up
Value: treatment response evaluation
Visa & medical-visa invite letter
Airport pickup & transfers

Cost of Transarterial Radioembolization- TARE in Major Cities of Malaysia

CityCost (USD)
Kuala Lumpur $15,000 – $25,000 Explore More

Transarterial Radioembolization Tare - Malaysia Vs the World

$5k - $35k
$7k - $0
$10k - $450k
$10k - $50k
$15k - $25k
$15k - $28k
$20k - $35k
$25k - $0
$25k - $45k
$30k - $45k
$60k - $0
Nimra Haseeb
Author

MSc Biochemistry

4 Years of Experience

Miss Nimra Haseeb is a medical researcher and a scientific content writer. She holds a Bachelor’s degree in Biotechnology and a Master’s in Biochemistry from Integral University, Lucknow. With strong experience in healthcare research, she specializes in secondary research, clinical data analysis, and evidence-based medical writing. Her work focuses on transforming complex scientific and medical information into clear, accurate, and reliable healthcare content for patients and healthcare audiences. She is also experienced in interpreting medical studies and healthcare trends to deliver well-researched and informative content that supports better health awareness and decision-making.
View More
Dr Prateek Varshney
Reviewer

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

15 min
Average response time

Serving Patients Worldwide in Multiple Languages.

An advanced interventional radiology treatment is transarterial radioembolisation (TARE), also known as selective internal radiation therapy (SIRT). It is used to manage liver tumours, particularly metastases to other body regions, such as hepatocellular carcinoma (HCC). In TARE, radioactive microspheres are selectively injected into the tumour's blood vessels, achieving localised radiation and tumour necrosis.

Transarterial radioembolization (TARE) is done to treat inoperable liver tumors, especially hepatocellular carcinoma (HCC) or liver metastases from other cancers. By introducing radioactive microspheres straight into the liver's bloodstream, it targets tumors and gives high-dose localized radiation without harming healthy tissue.

If you suffer from chronic upper abdominal pain, unexplained weight loss, exhaustion, jaundice, or loss of appetite , you should consult a physician, particularly if you have a history of cancer or liver illness. Early evaluation can help determine if TARE or another treatment is appropriate.

Physicians use imaging and a lung shunt test to map hepatic vessels and guarantee safe radiation administration in order to get ready for TARE. It may be necessary for patients to fast and modify their medication before to the surgery.

In TARE, the surgeon inserts a catheter through the groin or wrist into the hepatic artery supplying the liver tumour. Tiny radioactive beads (usually Yttrium-90) are delivered directly to the tumour site through the catheter. These beads release localised radiation, destroying cancer cells while reducing damage to healthy tissue.

Transarterial radioembolization (TARE) usually takes 1-3 hours, depending on the number of tumors to be treated and the complexity of the process.

  • Liver damage or inflammation
  • Gastrointestinal issues such as nausea, vomiting, or ulceration
  • Fever, pain, and fatigue.
  • Infection or bleeding at the catheter insertion site.

TARE improves symptoms by directly delivering targeted radiation to liver tumors while preserving healthy tissue. Compared to regular surgery, it is less painful and requires less recovery time.

Following TARE, post-operative recovery requires a few days of hospital monitoring to control fever, nausea, and pain. With routine follow-up imaging to evaluate tumor response, most patients can resume their regular activities within 1 to 2 weeks, however some may have post-embolization syndrome.

TARE has demonstrated positive results for patients with hepatocellular carcinoma (HCC), with tumor response rates of 40\u201360%. However, the success rate varies depending on the kind, size, and location of the tumor.

70–90%

Effective tumor control

1–2 days

Typical hospital stay

1–2 weeks

to typical return to work
Explore Hospitals ( 7 )

Kuala Lumpur, Malaysia

277+ Beds · 284+ Procedures
MSQH
Starting
USD 18000

Kuala Lumpur, Malaysia

499+ Beds · 296+ Procedures
JCI MSQH

Kuala Lumpur, Malaysia

724+ Beds · 278+ Procedures
ACHS
Starting
USD 10000

Kuala Lumpur, Malaysia

300+ Beds · 270+ Procedures
JCI
Starting
USD 10000

Kuala Lumpur, Malaysia

442+ Beds · 274+ Procedures
JCI
Starting
USD 18000

Kuala Lumpur, Malaysia

220+ Beds · 253+ Procedures
JCI MSQH
Starting
USD 12000

Kuala Lumpur, Malaysia

171+ Beds · 264+ Procedures
MSQH
Starting
USD 8000

Get Your Transarterial Radioembolization- TARE
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

Free Consultation No Obligation Personalized Treatment Plan Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Process Involved for Transarterial Radioembolization- TARE in Malaysia

  • Consultation: A complete discussion with an oncologist or interventional radiologist to assess the tumour size, liver function, diagnosis, and suitability for TARE.
  • Pre-procedure evaluation: Employing imaging examinations such as CT, MRI, and angiography to view the blood supply of the liver and the tumour can ensure that radioactive microspheres are supplied accurately.
  • Treatment Discussion: This article discusses the TARE treatment, which treats liver tumours by injecting radioactive microspheres into the hepatic artery.
  • Procedure planning involves preparing the radioactive microspheres for injection, mapping the blood arteries, and scheduling the catheter placement.
  • Post-procedure monitoring and follow-up visits are required to seek out any complications, including fever, nausea, or pain following the procedure.
  • Hepatocellular carcinoma (HCC)
  • Metastatic liver cancer
  • Recurrent liver cancer after surgery or other treatments
  • Liver cancer patients, especially those with hepatocellular carcinoma (HCC), metastatic liver cancer, or unresectable tumours, are recommended to receive transarterial radioembolisation (TARE).
  • Chemotherapy
  • Targeted therapy
  • TARE provides the potential for shrinking or controlling tumours through exposure to high doses of radiation aimed at liver cancers with the healthy liver tissue preserved.
  • Decreases the chance of liver cancer coming back.
  • Enhances a patient's chance of living with advanced liver cancer.
  • Lessens the adverse effects of traditional radiation therapy.
  • Perfect for individuals who are not good candidates for liver transplants or surgery.
  • Medical Oncologist:
  • Radiation Oncologist:
  • Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
  • Consult with Our Healthcare Expert: One of our qualified specialists will contact you for a consultation.
  • Receive a Detailed Treatment Plan: After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
  • Choose your preferred option: Choose the therapy option that best suits you.
  • Seamless Organization: We will manage all the details, including visas, flights, accommodations, and transfers, for a stress-free journey.
Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Ms. Monica
Ms. Monica
Monica from Ghana for AV Malformation Treatment in India

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…

Silim Shabani
Silim Shabani
Patient Testimonial: Silim Shabani for Ovarian Cancer Treatment in Turkey

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for…

Frequently Asked Questions

The cost of Transarterial Radioembolization (TARE) in Malaysia may vary depending on the type and extent of the liver tumour, the number of liver segments treated, the type and dose of radioactive microspheres, pre-treatment angiography, imaging requirements, hospital charges, specialist fees, and follow-up care. The overall cost may include diagnostic imaging, liver function tests, treatment planning, mapping angiography, radioactive microsphere administration, hospitalisation, medications, and post-treatment monitoring.MediGence can help international patients explore suitable interventional oncology centres and obtain an estimated treatment plan based on the patient’s diagnosis and clinical requirements.

The best hospitals in Malaysia for TARE are those with experienced interventional radiologists, medical oncologists, hepatologists, radiation oncologists, nuclear medicine specialists, and multidisciplinary liver tumour teams. Patients should consider hospitals with advanced angiography suites, nuclear medicine facilities, specialised liver cancer programmes, and expertise in selective internal radiation therapy.

Patients should choose an interventional radiologist or interventional oncologist experienced in liver-directed therapies and radioembolization. Important factors include the specialist’s experience with hepatic artery mapping, microsphere delivery, dosimetry, management of complex liver vascular anatomy, and treatment of primary or metastatic liver tumours.The treating team should assess liver function, tumour distribution, vascular anatomy, performance status, and previous cancer treatments before recommending TARE.

Transarterial Radioembolization (TARE) has an overall success rate of approximately 40–60%, depending on the tumour type, tumour burden, liver function, treatment intent, vascular anatomy, microsphere distribution, and response to therapy. Treatment outcomes may include tumour control, reduction in tumour size, symptom improvement, or downstaging in selected patients.The treating oncology team can provide a more individualised estimate after reviewing the patient’s imaging findings, liver function, and overall clinical condition.

Hospitals in Malaysia may use digital subtraction angiography, cone-beam CT, CT or MRI, nuclear medicine imaging, technetium-99m macroaggregated albumin (99mTc-MAA) mapping, personalised dosimetry, and yttrium-90 (Y-90) microspheres.TARE involves catheter-based delivery of radioactive microspheres into tumour-feeding branches of the hepatic artery. The microspheres deliver targeted internal radiation while limiting exposure to surrounding healthy liver tissue.Depending on the patient’s condition, TARE may be used as a definitive liver-directed treatment, for tumour control, as a bridge to transplantation, or in combination with systemic therapy or other locoregional treatments.

Possible risks and complications may include:
  • Fatigue, nausea, abdominal discomfort, or low-grade fever
  • Post-radioembolization syndrome
  • Temporary elevation of liver enzymes
  • Liver dysfunction or radiation-induced liver injury
  • Damage to non-target organs due to unintended microsphere delivery
  • Gastrointestinal ulceration or bleeding
  • Radiation pneumonitis in rare cases
  • Bile duct injury or gallbladder inflammation
  • Bleeding, infection, or vascular complications at the catheter entry site
  • Allergic or kidney-related complications from contrast material
  • Need for additional cancer treatment
  • The treating team will explain the potential risks based on the patient’s liver function, tumour characteristics, and planned treatment.

    Patients should share all relevant medical records with the treating oncology team before travelling. These may include CT or MRI scans, PET-CT reports when available, pathology reports, previous treatment records, liver function tests, blood counts, coagulation reports, kidney function tests, and information about current medications and allergies.Patients should also discuss the treatment timeline, pre-treatment mapping procedure, hospital stay, radiation safety instructions, follow-up imaging, and post-treatment monitoring before making travel arrangements.

    Yes. International patients can arrange an online consultation with an interventional radiologist, medical oncologist, or liver cancer specialist before travelling to Malaysia. The specialist may review tumour imaging, pathology findings, liver function, previous treatments, and overall health to determine whether TARE may be appropriate.MediGence can help coordinate online consultations and facilitate the sharing of relevant medical records with suitable specialists.

    International patients should carry a valid passport and relevant medical documents, including:
  • Recent liver CT, MRI, or PET-CT reports and images
  • Tumour biopsy or pathology reports
  • Previous oncology treatment records
  • Liver and kidney function test results
  • Complete blood count and coagulation reports
  • Previous angiography or interventional procedure records
  • Current prescriptions and medication details
  • Allergy and medical history records
  • The required stay in Malaysia depends on the treatment protocol, pre-treatment mapping, number of liver areas treated, and the patient’s recovery. TARE commonly involves a planning angiogram followed by the radioembolization procedure, which may be performed on separate days.Patients may need to remain in Malaysia for post-treatment observation, clinical assessment, and early follow-up. The treating team will recommend an appropriate stay based on the treatment plan and the patient’s clinical condition.

    Recovery after TARE is generally shorter than after open surgery, although fatigue, reduced appetite, nausea, or abdominal discomfort may occur for several days or weeks. Most patients can gradually resume routine activities based on their clinical condition and the treating team’s advice.Follow-up blood tests and imaging are required to assess liver function, treatment response, and possible complications.

    If complications occur, patients should contact the treating oncology or interventional radiology team or seek prompt medical attention. Urgent evaluation may be required for severe abdominal pain, persistent vomiting, high fever, jaundice, gastrointestinal bleeding, breathing difficulty, increasing abdominal swelling, confusion, or sudden worsening of symptoms.Patients should receive clear discharge instructions and a detailed follow-up plan before returning home.

    International patients can submit their medical details and relevant cancer imaging through the MediGence website. Following an initial review, the MediGence care team can help patients explore suitable hospitals and experienced interventional oncology specialists, coordinate consultations, and support treatment and medical travel planning.The final treatment recommendation is made by the multidisciplinary oncology team after a detailed clinical evaluation.

    International patients may choose Malaysia for access to experienced interventional radiologists, specialised liver cancer programmes, advanced angiography and nuclear medicine facilities, personalised radiation dosimetry, and multidisciplinary oncology care. The destination should be evaluated based on clinical expertise, treatment infrastructure, patient safety standards, and availability of follow-up services.

    Treatment options depend on the tumour type, number and location of liver lesions, liver function, vascular anatomy, disease stage, and previous treatments. Options may include:
  • Systemic therapy, including targeted therapy or immunotherapy
  • Surgical liver resection
  • Liver transplantation in eligible patients
  • Thermal ablation
  • Transarterial chemoembolization (TACE)
  • Transarterial Radioembolization (TARE) using Y-90 microspheres
  • External beam radiation therapy
  • Combination treatment with systemic or locoregional therapies
  • Supportive and symptom-directed care
  • The multidisciplinary oncology team will recommend the most appropriate treatment after reviewing the patient’s diagnosis, imaging findings, liver function, and overall clinical condition.

    International patients may choose Malaysia for access to specialised interventional oncology centres, experienced liver cancer specialists, advanced Y-90 radioembolization technology, personalised treatment planning, and comprehensive oncology support.MediGence can assist with hospital and specialist selection, medical record coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the patient’s cancer type, liver function, treatment requirements, and the hospital’s expertise in TARE.

    Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan